Healthy Skepticism Library
Items published in 2009
There are 1996 items in the Healthy Skepticism Library that were published in 2009.
Page 20 of 20 pages ‹ First < 18 19 20
HSL14930
Olver IN, Haines IE.
What changes are needed to the current direction and interpretation of clinical cancer research to meet the needs of the 21st century?
eMJA 2009; 190:(2):74-77
http://www.mja.com.au/public/issues/190_02_190109/olv10224_fm.html
HSL14946
Loukas E.
Sales Through Retail Pharmacies (Twelve months to November 2008*)
IMS 2009
http://view.respond.imshealth.com/?j=fe8a12757c66067471&m=fef31377726304&ls=fdf51577706d027d77137070&l=fe9c1570746204787
HSL14991
Sweet M.
Pharmaceutical marketing and the internet
Australian Prescriber 2009; 23:2-4
http://www.australianprescriber.com/magazine/32/1/2/4/
HSL15040
Stockigt JR.
The quality of medication information in Australia: the need for more clinical expertise and accountability
eMJA 2009; 190:(3):110-111
http://www.mja.com.au/public/issues/190_03_020209/sto11172_fm.html
HSL15045
Mansell P, Read J.
Posttraumatic stress disorder, drug companies, and the internet.
J Trauma Dissociation 2009; 10:(1):9-23
http://www.ncbi.nlm.nih.gov/pubmed/19197709
HSL15046
Alkhateeb FM, Khanfar NM, Clauson KA.
Characteristics of physicians who frequently see pharmaceutical sales representatives.
J Hosp Mark Public Relations 2009; 19:(1):2-14
http://www.ncbi.nlm.nih.gov/pubmed/19197653
HSL15047
Polen HH, Khanfar NM, Clauson KA.
Impact of Direct-to-Consumer Advertising (DTCA) on Patient Health-Related Behaviors and Issues.
Health Mark Q. 2009; 26:(1):42-55
http://www.ncbi.nlm.nih.gov/pubmed/19197587
HSL15165
Elshaug AG, Moss JR, Littlejohns P, Karnon J, Merlin TL, Hiller JE.
Identifying existing health care services that do not provide value for money
Med J Aust 2009; 190:(5):269-273
http://www.mja.com.au/public/issues/190_05_020309/ell10663_fm.html
HSL15177
PriceWaterhouseCoopers
Pharma 2020: Marketing the future: Which path will you take?
: PriceWaterhouseCoopers 2009
http://www.pwc.com/Extweb/pwcpublications.nsf/docid/B1221EC9D057309F852575610076732C
HSL15182
Aronson JK, Price D, Ferner RE
A strategy for regulatory action when new adverse effects of a licensed product emerge.
Drug Saf 2009; 32:(2):91-8
http://www.ncbi.nlm.nih.gov/pubmed/19236116?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
HSL15262
Leo J, Lacasse JR.
Consumer advertisements of medications for ADHD
Tamimi S, Leo J. Rethinking ADD: From Brain To Culture. New York: Palgrave Macmillan 2009
http://www.amazon.com/Rethinking-ADHD-Culture-Sami-Timimi/dp/0230507123
HSL15382
Abelson J, Collins PA.
Media Hyping and the 'Herceptin Access Story': An Analysis of Canadian and UK Newspaper Coverage
Healthcare Policy / Politiques de Santé 2009; 4:(3):e113-e128
http://www.longwoods.com/product.php?productid=20474&cat=582
HSL15505
Mulki JP, Jaramillo JF, Locander WB.
Critical Role of Leadership on Ethical Climate and Salesperson Behaviors
Journal of Business Ethics 2009; (86):125-141
http://www.springerlink.com/content/355705k570264364/
HSL15524
Jureidini J
How do we Safely Treat Depression in Children, Adolescents and Young Adults?
Drug Saf 2009; 32:(4):275-82
http://www.ncbi.nlm.nih.gov/pubmed/19388719
HSL15541
Rod M, Saunders S.
The informative and persuasive components of pharmaceutical
International Journal of Advertising 2009; 28:(2):313-349
http://www.internationaljournalofadvertising.com/
HSL15568
Manhattan Research
The Absolute, Relative, and Incremental ROI of DTC Digital Marketing
: Manhattan Research 2009
http://www.manhattanresearch.com/files/White_Papers/The_Absolute_Relative_and_Incremental_ROI_of_DTC_Digital_Marketing.pdf
HSL15625
Molnar FJ, Man-son-hing M, Hutton B, Fergusson DA.
Have last-observation-carried-forward analyses caused us to favour more toxic dementia therapies over less toxic alternatives? A systematic review
Open Medicine 2009; 3:(2):
http://www.openmedicine.ca/article/view/245/230
HSL15626
Altman DG.
Missing outcomes in randomized trials: addressing the dilemma
Open Medicine 2009; 3:(2):
http://www.openmedicine.ca/article/view/323/232
HSL15635
Food and Drug Administration
RE: NDA #20-449 Taxotere® (docetaxel) Injection Concentrate, Intravenous Infusion (IV)
: Food and Drug Administration 2009
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/UCM153134.pdf
HSL15700
Jureidini JN, McHenry LB.
Key Opinion Leaders and Paediatric Antidepressant Overprescribing
Psychotherapy and Psychosomatics 2009; 78:(4):197-201
http://www.online.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&ArtikelNr=214440&Ausgabe=248735&ProduktNr=223864&filename=214440.pdf
HSL15785
Vandereycken W.
[An analysis of advertisements for psychotropic drugs in the Dutch Journal of Psychiatry ('Tijdschrift voor Psychiatrie')].
Tijdschr Psychiatr. 2009; 51:(6):407-11
http://www.tijdschriftvoorpsychiatrie.nl/en/tijdschrift/artikel/TVPart_2796
HSL15786
Greene JA, Podolsky SH
Keeping modern in medicine: pharmaceutical promotion and physician education in postwar america.
Bull Hist Med 2009; 83:(2):331-77
http://muse.jhu.edu/journals/bulletin_of_the_history_of_medicine/v083/83.2.greene.html
HSL15834
Liang BA, Mackey T.
Searching for safety: addressing search engine, website, and provider accountability for illicit online drug sales.
Am J Law Med. 2009; 35:(1):125-84
http://www.ncbi.nlm.nih.gov/pubmed/19534258
HSL15881
Rojas M.
Price discrimination by pharmaceutical companies across Central American countries
International Journal of Pharmaceutical and Healthcare Marketing 2009; 3:(2):118 - 136
http://www.emeraldinsight.com/Insight/viewContentItem.do?contentType=Article&contentId=1796048
HSL15882
Kalyanaram GK.
The endogenous modeling of the effect of direct-to-consumer advertising in prescription drugs
International Journal of Pharmaceutical and Healthcare Marketing 2009; 3:(2):137 - 148
http://www.emeraldinsight.com/Insight/viewContentItem.do?contentType=Article&contentId=1796049
HSL15963
Greenland S.
Accounting for uncertainty about investigator bias: disclosure is informative: How could disclosure of interests work better in medicine, epidemiology and public health?
Journal of Epidemiology and Community Health 2009; 63:593-598
http://jech.bmj.com/cgi/content/extract/63/8/593?etoc
HSL15964
Michaels D.
Addressing conflict in strategic literature reviews: disclosure is not enough: How could disclosure of interests work better in medicine, epidemiology and public health?
J Epidemiol Community Health 2009; 63:599-600
http://jech.bmj.com/cgi/content/extract/63/8/599?etoc
HSL15965
Weed DL.
Conflicts of interest: How could disclosure of interests work better in medicine, epidemiology and public health?
J Epidemiol Community Health 2009; 63:(8):601-602
http://jech.bmj.com/cgi/content/extract/63/8/601?etoc
HSL15966
Spelsberg A, Martiny A, Schoenhoefer PS.
Is disclosure of potential conflicts of interest in medicine and public health sufficient to increase transparency and decrease corruption?: How could disclosure of interests work better in medicine, epidemiology and public health?
J Epidemiol Community Health 2009; 63:(8):603-605
http://jech.bmj.com/cgi/content/extract/63/8/603?etoc
HSL15967
Wagner W, McGarity T.
Regulatory reinforcement of journal conflict of interest disclosures: How could disclosure of interests work better in medicine, epidemiology and public health?
J Epidemiol Community Health 2009; 63:(8):606-607
http://jech.bmj.com/cgi/content/extract/63/8/606?etoc
HSL15968
Marcovitch H.
How do potential conflicts of interest confuse medicine and public health? How could disclosure of interests work better in medicine, epidemiology and public health?
J Epidemiol Community Health 2009; 63:(8):608-609
http://jech.bmj.com/cgi/content/extract/63/8/608?etoc
HSL15970
12th Annual Survey on Consumer Reaction to DTC Advertising of Prescription Drugs Reveals: Nearly 50% of Online Consumers Report Health Videos a Top Resource
Pharma Live 2009
http://pharmalive.com/news/index.cfm?articleID=638484
HSL15987
Bove AA.
President's Page: Relations With Industry: Thoughts on Claims of a Broken System
J Am Coll Cardiol 2009; 54:(2):177-179
http://content.onlinejacc.org/cgi/content/full/54/2/177
HSL16018
O'Meara A.
Chasing Medical Miracles - The Promise and Perils of Clinical Trials
: Walker Books 2009
http://www.walkerbooks.com/books/catalog.php?key=818
HSL16023
Glasziou PP.
Promoting evidence-based non-drug interventions: time for a non-pharmacopoeia?
MJA 2009; 191:(2):52-53
http://www.mja.com.au/public/issues/191_02_200709/gla10407_fm.html
HSL16024
Lexchin J.
CJEM and pharmaceutical advertisements: it’s time for an end
CJEM 2009; 11:(4):375-9
http://www.cjem-online.ca/v11/n4/p375
HSL16080
Limbu Y, Torres IM.
The effects of involvement and ad type on attitudes toward direct-to-consumer advertising of prescription drugs.
J Health Hum Serv Adm 2009 Sum; 32:(1):107-38
http://www.ncbi.nlm.nih.gov/pubmed/19558035
HSL16098
Rutherford BR, Sneed JR, Roose SP.
Does study design influence outcome? The effects of placebo control and treatment duration in antidepressant trials.
Psychother Psychosom 2009; 78:(3):172-81
http://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=000209348
HSL16100
Kale SA, Barkin RL.
Resuscitation and rescue of the pharmaceutical detail: a prescriber-drug representative collaboration.
Compr Ther 2009 Sum; 35:(2):68-71
http://www.ncbi.nlm.nih.gov/pubmed/19618754
HSL16164
Martin JH, Beer C, Morris RG, Doogue MP.
Doctors and the pharmaceutical industry: time for a national policy?
MJA 2009; 191:(3):189-190
http://www.mja.com.au/public/issues/191_03_030809/letters_030809_fm-4.html
HSL16254
Taylor D
Branding Q&A
MedAdNews 2009
http://medad.canon-experts.com/expert/dale-taylor/
HSL16285
Wyeth Ghostwriting Archive
PLoS Med 2009;
http://www.plosmedicine.org/static/ghostwriting.action
HSL16459
Gérvas J, Mansfield PR
Physicians, the industry and population health
Journal of Epidemiology and Community Health 2009; 63:(10):773-774
http://jech.bmj.com/cgi/content/extract/63/10/773
HSL16469
Van Der Weyden MB
Confronting conflict of interest
eMJA 2009; 191:(5):241
http://www.mja.com.au/public/issues/191_05_070909/martin_070909.html
HSL16529
Gülöksüz S, Oral ET, Ulaş H.
[Attitudes and behaviors of psychiatry residents and psychiatrists working in training institutes towards the relationship between the pharmaceutical industry and physicians].
Turk Psikiyatri Derg 2009; 20:(3):236-42
http://www.turkpsikiyatri.com/ftr.aspx?id=714
HSL16557
Tipton M, Bharadwaj S, Robertson D
Regulatory Exposure of Deceptive Marketing and its Impact on Firm Value
Journal of Marketing 2009;
http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1431978
HSL16669
Kalb PE, Greenberg PE.
Legal and economic perspectives concerning US government investigations of alleged off-label promotion by drug manufacturers.
Pharmacoeconomics 2009; 27:(8):623-5
http://www.ncbi.nlm.nih.gov/pubmed/19835018
HSL16758
Egilman D
Just say no
BMJ 2009; 339:b4527
http://www.bmj.com/cgi/content/short/339/nov02_2/b4527?rss=1
HSL16769
Zinner DE, Bjankovic D, Clarridge B, Blumenthal D, Campbell EG
Participation Of Academic Scientists In Relationships With Industry
Health Affairs 2009; 28:(6):1814
http://content.healthaffairs.org/cgi/content/abstract/28/6/1814
HSL16810
Evidence and Recommendations for a Model PharmFree Curriculum
PharmFree 2009
http://www.pharmfree.org/tools/resources_documents/files/ModelPharmFreeCurriculum_Final.pdf
HSL16863
de Barros JA
Medicamentos: una contribución a la reflexión hacia su uso racional
RISAI 2009; 1:(3):1-5
http://pub.bsalut.net/cgi/viewcontent.cgi?article=1027&context=risai
HSL16887
Ghaemi SN
The failure to know what isn't known: negative publication bias with lamotrigine and a glimpse inside peer review
Evid Based Mental Health 2009; 12:(3):65
http://ebmh.bmj.com/content/12/3/65.full
HSL16925
The Royal Australian and New Zealand College of Psychiatrists
Symposium on Commercial Sponsorship of Psychiatrist Education
2009
http://ranzcp.cmsaustralasia.com/video.load.php?videosource=rtmp://ocy932wr.rtmphost.com/09175/Panel_LR.FLV
HSL16933
Sweet MA, Simons MJ
As mass media evolves into 'masses of media', what are the implications for our health?
Med J Aust 2009; 191:(11/12):618-619
http://www.mja.com.au/public/issues/191_11_071209/swe11253_fm.html
HSL16934
Chapman S, Holding SJ, Ellerm J, Heenan RC, Fogarty AS, Imison M, Mackenzie R, McGeechan K
The content and structure of Australian television reportage on health and medicine, 2005-2009: parameters to guide health workers
Med J Aust 2009; 191:(11/12):620-624
http://www.mja.com.au/public/issues/191_11_071209/cha10706_fm.html
HSL16935
Medicines Australia Code of Conduct: breaches
Aust Prescr 2009
http://www.australianprescriber.com/magazine/32/6/160/1/
HSL16937
Archontaki M, Symvoulakis EK, Hajiioannou JK, Stamou AK, Kastrinakis S, Bizaki AJ, Kyrmizakis DE.
Increased frequency of rhinitis medicamentosa due to media advertising for nasal topical decongestants.
B-ENT 2009; 5:(3):159-62
http://www.ncbi.nlm.nih.gov/pubmed/19902852
HSL17018
Sismondo S, Nicholson SH.
Publication planning 101.
J Pharm Pharm Sci 2009; 12:(3):273-9
http://ejournals.library.ualberta.ca/index.php/JPPS/article/viewFile/6299/5594
HSL17053
Idris KM, Yousif MA, Mustafa AF
Influence of pharmaceutical industry's promotion on the doctors' prescribing patterns in Sudan
The Journal of Medicine Use in Developing Countries 2009; 1:(3):3- 13
www.usm.my/dsap/journal/article/disember2009/Article2.pdf
HSL17201
Ball JG, Liang A, Lee WN.
Representation of African Americans in direct-to-consumer pharmaceutical commercials: a content analysis with implications for health disparities.
Health Mark Q 2009; 26:(4):372-90
http://www.ncbi.nlm.nih.gov/pubmed/19916100
HSL17202
Fogel J, Novick D.
Direct-to-consumer advertisements of prescription medications over the Internet.
Health Mark Q 2009; 26:(4):347-71
http://www.ncbi.nlm.nih.gov/pubmed/19916099
HSL17203
Bhutada NS, Cook CL, Perri M 3rd.
Consumers responses to coupons in direct-to-consumer advertising of prescription drugs.
Health Mark Q 2009; 26:(4):333-46
http://www.ncbi.nlm.nih.gov/pubmed/19916098?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=2
HSL17204
DeLorme DE, Huh J, Reid LN.
Direct-to-consumer advertising skepticism and the use and perceived usefulness of prescription drug information sources.
Health Mark Q 2009; 26:(4):293-314
http://www.ncbi.nlm.nih.gov/pubmed/19916096
HSL17205
Silver LS, Stevens RE, Loudon D.
Direct-to-consumer advertising of pharmaceuticals: concepts, issues, and research.
Health Mark Q 2009; 26:(4):251-8
http://www.ncbi.nlm.nih.gov/pubmed/19916093
HSL17354
Smith BD
An exploratory study of key opinion leadership management trends among European pharmaceutical companies
Journal of Medical Marketing 2009; 9:(4):291–300
http://www.palgrave-journals.com/jmm/journal/v9/n4/abs/jmm200931a.html
HSL17357
Michael Stros, Juerg Hari, John Marriott
The relevance of marketing activities in the Swiss prescription drugs market: Two empirical qualitative studies
International Journal of Pharmaceutical and Healthcare Marketing 2009; 3:(4):323 - 346
http://www.emeraldinsight.com/Insight/viewContentItem.do?contentType=Article&contentId=1826906
HSL17660
Goldacre B
Bad Science : HarperCollins 2009
http://www.harpercollins.co.uk/Titles/36492/bad-science-ben-goldacre-9780007284870
HSL17849
Villanueva T
Centro Vasco de Información de Medicamentos CEVIME-MIEZ
Rev Port Clin Geral 2009; 25:724
http://www.osanet.euskadi.net/r8520361/es/ contenidos/informacion/presentacion_cevime/ es_1219/indice_c.html
HSL18178
Fava GA
The Decline of Pharmaceutical Psychiatry and the Increasing Role of Psychological Medicine
Psychother Psychosom 2009; 78:(4):220-227
http://content.karger.com/produktedb/produkte.asp?doi=214443
HSL18637
Nelson DE, Hesse BW, Croyle RT
Making Data Talk: Communicating Public Health Data to the Public, Policy Makers, and the Press : Oxford University Press 2009
HSL18720
Herzberg D.
'Will wonder drugs never cease!': a prehistory of direct-to-consumer advertising.
Pharm Hist 2009; 51:(2):47-56
http://www.ncbi.nlm.nih.gov/pubmed/20853552
HSL19570
Bunniran S, McCaffrey DJ 3rd, Bentley JP, Bouldin AS.
Pharmaceutical product withdrawal: attributions of blame and its impact on trust.
Res Social Adm Pharm 2009; 5:(3):262-73
http://www.rsap.org/article/S1551-7411(08)00096-X/abstract
HSL16353
Young T
Death by Prescription Toronto: Key Porter Books 2009
http://www.amazon.ca/Death-Prescription-Father-Daughters-Killer/dp/1552638251
HSL16381
Moynihan R
Drug Safety: Battle over popular bone drug Fosamax bursts into court
BMJ 2009 08 06;
http://www.bmj.com/cgi/content/extract/339/aug06_1/b3155
HSL16384
Exorcising authors
The Finanical Times 2009 08 30
http://www.ft.com/cms/s/0/f7434ad6-9588-11de-90e0-00144feabdc0.html?nclick_check=1
HSL16393
Bextra Whistleblower Case Started Investigation of Pfizer
Reuters 2009 09 02
http://www.reuters.com/article/pressRelease/idUS158792+02-Sep-2009+PRN20090902
HSL16420
Parsai G
Modify the pill advertisements, Drug Controller asks manufacturers
The Hindu 2009 09 09
http://beta.thehindu.com/news/national/article17177.ece
HSL16454
Williams SJ, Gabe J, Davis P
Pharmaceuticals and Society: Critical Discourses and Debates : Wiley-Blackwell 2009
http://au.wiley.com/WileyCDA/WileyTitle/productCd-1405190841,descCd-description.html
HSL16457
Hutton D
Whistleblowing at Health Canada: Chopra speaks out
CMAJ 2009 09 15; 181:(6-7):
http://www.cmaj.ca/cgi/content/full/181/6-7/E121
HSL16472
PharmaTimes Great Oxford Debate - 2009
Pharma Times 2009
http://www.pharmatimes.com/Competitions/Great-Oxford-Debate/2009debate.aspx
HSL16546
Sawaya L
The Persuasion Report Orleans, Canada: Reticulum 2009
https://cp.experthost.com/ssl/18/reticulum.ca/books_s3.php
HSL16587
Issues and Challenges Related to Local Television: Report of the Standing Committee on Canadian Heritage
: House of Commons, Canada 2009 Jun
http://www2.parl.gc.ca/HousePublications/Publication.aspx?DocId=4005108&Language=E&Mode=1&Parl=40&Ses=2
HSL16592
Krimsky S, Sweet E
An Analysis of Toxicology and Medical Journal Conflict-of-Interest Polices
Accountability in Research 2009; 16:(5):235 - 253
http://www.informaworld.com/smpp/content~db=all~content=a914972083
HSL16601
Evaluating evolving sales models & advanced technology for a customer centric approach
Pharmaceutical Sales Force Effectiveness Strategies 2009 Aug
http://www.reportlinker.com/p0148147/Pharmaceutical-Sales-Force-Effectiveness-Strategies-Evaluating-evolving-sales-models--advanced-technology-for-a-customer-centric-approach.html
HSL16656
Anvisa não pode regulamentar publicidade, diz juiz
Consultor Jurídico 2009 10 23
http://www.conjur.com.br/2009-out-23/anvisa-nao-competencia-regulamentar-publicidade-juiz
HSL16678
Perrone M
GAO: FDA fails to follow up on unproven drugs
Yahoo News 2009 10 26
http://news.yahoo.com/s/ap/20091026/ap_on_he_me/us_fda_unproven_drugs
HSL16679
FDA Needs to Enhance Its Oversight of Drugs Approved on the Basis of Surrogate Endpoints
United States Government Accountability Office 2009 Sep
http://www.gao.gov/new.items/d09866.pdf
HSL16996
Dunn A
Best Strategic Learning Investment in 2010?
Hoenig Carlson E Courtney Justice, The Cournell Group 2009 Dec
http://docs.google.com/fileview?id=0B2pN9F6nMK5MZjQ2MjEyYjMtNzc5Yi00NjVjLWIwZmItYTI1NDZlZTk2NDgw&hl=en
HSL17400
Haag D
rapport in het kader van algemeen toezicht naar aanleiding van het onderzoek bij Sanofi Pasteur MSD naar het geneesmiddel Gardasil (Report about Sanofi)
Staatstoezicht Op De Volksgezondheid 2009 July
http://www.spmsd.nl/143608/Rapport-inspectie-nav-WOB-verzoek.pdf
HSL17401
Haag D
Rapport in het kader van algemeen toezicht naar annleiding van het onderzoek bij GSK naar geneesmiddel Cervarix
Staatstoezicht Op De Volksgezondheid 2009 July
http://www.gsk.nl/downloads/files/rapportonderoekbijGSKnaargeneesmiddelCervarix.pdf
HSL19165
Herzberg D.
'Will wonder drugs never cease!': a prehistory of direct-to-consumer advertising.
Pharm Hist 2009; 51:(2):47-56
http://www.ncbi.nlm.nih.gov/pubmed/20853552
HSL19166
Karlowicz KA.
Direct-to-consumer advertising for erectile dysfunction drugs.
Urol Nurs 2009; 29:(4):214
http://www.ncbi.nlm.nih.gov/pubmed/19718935
HSL19167
Stell LK.
Drug reps off campus! Promoting professional purity by suppressing commercial speech.
J Law Med Ethics 2009; 37:(3):431-43,
http://onlinelibrary.wiley.com/doi/10.1111/j.1748-720X.2009.00404.x/abstract
HSL19168
Tamimi NA, Ellis P.
Drug development: from concept to marketing!
Nephron Clin Pract. 2009; 113:(3):c125-31
http://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=000232592
HSL19374
Rothman DJ, McDonald WJ, Berkowitz CD, Chimonas SC, DeAngelis CD, Hale RW, Nissen SE, Osborn JE, Scully JH Jr, Thomson GE, Wofsy D.
Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest.
JAMA 2009 1; 301:(13):1367-72
http://jama.ama-assn.org/content/301/13/1367.long
HSL19722
Jutel A, Menkes DB.
'But doctors do it...': nurses' views of gifts and information from the pharmaceutical industry
Ann Pharmacother. 2009; 43:(6):1057-63
http://www.theannals.com/content/43/6/1057.long
Page 20 of 20 pages ‹ First < 18 19 20
